Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) develops, produces and sells food and feed additives for the pharmaceutical, nutritional, food and animal feed industries; its core vitamin products include biotin and folic acid, while its Silver-Elephant Bio-engineering Co., Ltd. subsidiary manufactures biological preservatives such as nisin and natamycin, alongside intermediate active pharmaceutical ingredients (APIs). The company, founded in 1999 and headquartered at No. 789 Renmin East Road, Tiantai, Zhejiang, China, operates primarily in China with exports to global markets and adheres to GMP standards, holding certifications including ISO22000, BRC, FAMI-QS and OHSAS18001; it maintains a provincial high-tech R&D center, Academician Workstation and strong research capabilities in vitamin B group products and bio-preservatives, supported by talents from Zhejiang and National Thousand Talents Programs. In recent developments, the company completed non-trading transfers under its 2024 Employee Stock Ownership Plan in October 2025, received funding from Tibet Xingrui Enterprise Management Partnership and pursued forward integration by elevating biotin and folic acid into higher-end pharmaceutical API markets, including obtaining CEP certification for biotin and achieving substantial sales growth in CEP biotin and API folic acid during 2022 that continued to shape its strategic focus.